Literature DB >> 11099949

Overexpression of CDC25A associated with poor prognosis in breast cancer

.   

Abstract

Entities:  

Year:  2000        PMID： 11099949     DOI： 10.1016/s1357-4310(00)01824-4

Source DB:  PubMed          Journal:  Mol Med Today        ISSN： 1357-4310


× No keyword cloud information.
  5 in total

1.  3,3'-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated Cdc25A degradation.

Authors:  Yucui Jin
Journal:  Mol Cell Biochem       Date:  2011-07-15       Impact factor: 3.396

2.  PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage.

Authors:  E Bobrovnikova-Marjon; C Grigoriadou; D Pytel; F Zhang; J Ye; C Koumenis; D Cavener; J A Diehl
Journal:  Oncogene       Date:  2010-05-10       Impact factor: 9.867

3.  Dysregulation of the TGF-beta postreceptor signaling pathway in cell lines derived from primary or metastatic ovarian cancer.

Authors:  Ling Xi; Wei Hu; Li Meng; Jianfeng Zhou; Yunping Lu; Changyu Wang; Ding Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

4.  Elevated EXO1 expression is associated with breast carcinogenesis and poor prognosis.

Authors:  Jingjing Liu; Jin Zhang
Journal:  Ann Transl Med       Date:  2021-01

5.  Identification of a gene signature in cell cycle pathway for breast cancer prognosis using gene expression profiling data.

Authors:  Jiangang Liu; Andrew Campen; Shuguang Huang; Sheng-Bin Peng; Xiang Ye; Mathew Palakal; A Keith Dunker; Yuni Xia; Shuyu Li
Journal:  BMC Med Genomics       Date:  2008-09-11       Impact factor: 3.063
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.